{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:45:28Z","timestamp":1790484328619,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,6,15]],"date-time":"2010-06-15T00:00:00Z","timestamp":1276560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s00198-010-1320-4","type":"journal-article","created":{"date-parts":[[2010,6,14]],"date-time":"2010-06-14T10:24:30Z","timestamp":1276511070000},"page":"731-737","source":"Crossref","is-referenced-by-count":12,"title":["Risk of fractures associated with treatment for benign prostate hyperplasia in men"],"prefix":"10.1007","volume":"22","author":[{"given":"P.","family":"Vestergaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Rejnmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mosekilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,15]]},"reference":[{"key":"1320_CR1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ucl.2009.07.003","volume":"36","author":"W Bushman","year":"2009","unstructured":"Bushman W (2009) Etiology, epidemiology, and natural history of benign prostatic hyperplasia. Urol Clin N Am 36:403\u2013415, v","journal-title":"Urol Clin N Am"},{"key":"1320_CR2","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1210\/jc.81.3.1031","volume":"81","author":"SR Tollin","year":"1996","unstructured":"Tollin SR, Rosen HN, Zurowski K, Saltzman B, Zeind AJ, Berg S, Greenspan SL (1996) Finasteride therapy does not alter bone turnover in men with benign prostatic hyperplasia\u2013a Clinical Research Center study. J Clin Endocrinol Metab 81:1031\u20131034","journal-title":"J Clin Endocrinol Metab"},{"key":"1320_CR3","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.urology.2004.07.031","volume":"64","author":"B Djavan","year":"2004","unstructured":"Djavan B, Chapple C, Milani S, Marberger M (2004) State of the art on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Urol 64:1081\u20131088","journal-title":"Urol"},{"key":"1320_CR4","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1001\/jama.300.14.1660","volume":"300","author":"SJ Jacobsen","year":"2008","unstructured":"Jacobsen SJ, Cheetham TC, Haque R, Shi JM, Loo RK (2008) Association between 5-alpha reductase inhibition and risk of hip fracture. JAMA 300:1660\u20131664","journal-title":"JAMA"},{"key":"1320_CR5","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.juro.2008.01.145","volume":"179","author":"JK Amory","year":"2008","unstructured":"Amory JK, Anawalt BD, Matsumoto AM, Page ST, Bremner WJ, Wang C, Swerdloff RS, Clark RV (2008) The effect of 5alpha-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, prostate specific antigen and sexual function in healthy young men. J Urol 179:2333\u20132338","journal-title":"J Urol"},{"key":"1320_CR6","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2265.1992.tb02355.x","volume":"37","author":"H Matzkin","year":"1992","unstructured":"Matzkin H, Chen J, Weisman Y, Goldray D, Pappas F, Jaccard N, Braf Z (1992) Prolonged treatment with finasteride (a 5 alpha-reductase inhibitor) does not affect bone density and metabolism. Clin Endocrinol (Oxf) 37:432\u2013436","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1320_CR7","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0022-5347(05)65095-1","volume":"167","author":"AM Matsumoto","year":"2002","unstructured":"Matsumoto AM, Tenover L, McClung M, Mobley D, Geller J, Sullivan M, Grayhack J, Wessells H, Kadmon D, Flanagan M, Zhang GK, Schmidt J, Taylor AM, Lee M, Waldstreicher J (2002) The long-term effect of specific type II 5alpha-reductase inhibition with finasteride on bone mineral density in men: results of a 4-year placebo controlled trial. J Urol 167:2105\u20132108","journal-title":"J Urol"},{"key":"1320_CR8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0302-2838(03)00198-2","volume":"44","author":"GL Andriole","year":"2003","unstructured":"Andriole GL, Kirby R (2003) Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia. Eur Urol 44:82\u201388","journal-title":"Eur Urol"},{"key":"1320_CR9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0149-2918(01)80022-9","volume":"23","author":"E Chrischilles","year":"2001","unstructured":"Chrischilles E, Rubenstein L, Chao J, Kreder KJ, Gilden D, Shah H (2001) Initiation of nonselective alpha1-antagonist therapy and occurrence of hypotension-related adverse events among men with benign prostatic hyperplasia: a retrospective cohort study. Clin Ther 23:727\u2013743","journal-title":"Clin Ther"},{"key":"1320_CR10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1023\/A:1017595818158","volume":"32","author":"S Dutkiewics","year":"2001","unstructured":"Dutkiewics S (2001) Efficacy and tolerability of drugs for treatment of benign prostatic hyperplasia. Int Urol Nephrol 32:423\u2013432","journal-title":"Int Urol Nephrol"},{"key":"1320_CR11","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/pds.1402","volume":"16","author":"GC Hall","year":"2007","unstructured":"Hall GC, McMahon AD (2007) Comparative study of modified release alpha-blocker exposure in elderly patients with fractures. Pharmacoepidemiol Drug Saf 16:901\u2013907","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1320_CR12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3961\/jpmph.2009.42.3.165","volume":"42","author":"J Lee","year":"2009","unstructured":"Lee J, Choi NK, Jung SY, Kim YJ, Seong JM, Oh SJ, Park BJ (2009) The risk of fracture with taking alpha blockers for treating benign prostatic hyperplasia. J Prev Med Public Health 42:165\u2013170","journal-title":"J Prev Med Public Health"},{"key":"1320_CR13","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2796.2003.01227.x","volume":"254","author":"PC Souverein","year":"2003","unstructured":"Souverein PC, Van Staa TP, Egberts ACG, De la Rosette JJMCH, Cooper C, Leufkens HGM (2003) Use of alpha-blockers and the risk of hip\/femur fractures. J Intern Med 254:548\u2013554","journal-title":"J Intern Med"},{"key":"1320_CR14","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2796.2006.01695.x","volume":"260","author":"M Wiens","year":"2006","unstructured":"Wiens M, Etminan M, Gill SS, Takkouche B (2006) Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies. J Intern Med 260:350\u2013362","journal-title":"J Intern Med"},{"key":"1320_CR15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0006-2952(00)00591-8","volume":"61","author":"T Takeuchi","year":"2001","unstructured":"Takeuchi T, Tsuboi T, Arai M, Togari A (2001) Adrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblast-like cells. Biochem Pharmacol 61:579\u2013586","journal-title":"Biochem Pharmacol"},{"key":"1320_CR16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00198-004-1680-8","volume":"16","author":"P Vestergaard","year":"2005","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2005) Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark. Osteoporos Int 16:134\u2013141","journal-title":"Osteoporos Int"},{"key":"1320_CR17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/eat.10101","volume":"32","author":"P Vestergaard","year":"2002","unstructured":"Vestergaard P, Emborg C, St\u00f8ving R, Hagen C, Mosekilde L, Brixen K (2002) Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders\u2014 a nationwide register study. Int J Eat Disord 32:301\u2013308","journal-title":"Int J Eat Disord"},{"key":"1320_CR18","first-page":"263","volume":"46","author":"T Andersen","year":"1999","unstructured":"Andersen T, Madsen M, J\u00f8rgensen J, Mellemkj\u00e6r L, Olsen J (1999) The Danish National Hospital Register. Dan Med Bull 46:263\u2013268","journal-title":"Dan Med Bull"},{"key":"1320_CR19","first-page":"3741","volume":"157","author":"J Mosbech","year":"1995","unstructured":"Mosbech J, J\u00f8rgensen J, Madsen M, Rostgaard K, Thornberg K, Poulsen T (1995) The Danish National Patient Register: evaluation of data quality. Ugeskr Laeger 157:3741\u20133745","journal-title":"Ugeskr Laeger"},{"key":"1320_CR20","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/j.0013-9580.2004.18804.x","volume":"45","author":"P Vestergaard","year":"2004","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2004) Fracture risk associated with use of anti-epileptic drugs. Epilepsia 45:1330\u20131337","journal-title":"Epilepsia"},{"key":"1320_CR21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"M Charlson","year":"1987","unstructured":"Charlson M, Pompei P, Ales K, MacKenzie C (1987) A method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40:373\u2013383","journal-title":"J Chron Dis"},{"key":"1320_CR22","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/14034940500441223","volume":"34","author":"P Vestergaard","year":"2006","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2006) Socioeconomic aspects of fractures within universal public healthcare: a nationwide case-control study from Denmark. Scand J Public Health 34:371\u2013377","journal-title":"Scand J Public Health"},{"key":"1320_CR23","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00198-004-1734-y","volume":"16","author":"J Kanis","year":"2005","unstructured":"Kanis J, Johansson H, Johnell O, Oden A, De Laet C, Eisman J, Pols H, Tenenhouse A (2005) Alcohol intake as a risk factor for fracture. Osteoporos Int 16:737\u2013742","journal-title":"Osteoporos Int"},{"key":"1320_CR24","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","volume":"15","author":"C Klotzbuecher","year":"2000","unstructured":"Klotzbuecher C, Ross P, Landsman P, Abbott T III, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the litterature and statistical synthesis. J Bone Miner Res 15:721\u2013739","journal-title":"J Bone Miner Res"},{"key":"1320_CR25","first-page":"82","volume":"44","author":"P Munk-J\u00f8rgensen","year":"1997","unstructured":"Munk-J\u00f8rgensen P, Mortensen P (1997) The Danish Psychiatric Central Register. Dan Med Bull 44:82\u201384","journal-title":"Dan Med Bull"},{"key":"1320_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/aje\/kwf007","volume":"156","author":"P Vestergaard","year":"2002","unstructured":"Vestergaard P, Mosekilde L (2002) Fracture risk in patients with celiac disease, Crohn's disease, and ulcerative colitis: a nation-wide follow-up study in 16,416 patients in Denmark. Am J Epidemiol 156:1\u201310","journal-title":"Am J Epidemiol"},{"key":"1320_CR27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1042\/cs0710239","volume":"71","author":"P Strazzullo","year":"1986","unstructured":"Strazzullo P, Galletti F, Cirillo M, Siani A, Nunziata V, Giannattasio R, Mancini M (1986) Altered extracellular calcium homoeostasis in essential hypertension: a consequence of abnormal cell calcium handling. Clin Sci (Lond) 71:239\u2013244","journal-title":"Clin Sci (Lond)"},{"key":"1320_CR28","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.hjh.0000203845.26690.cb","volume":"24","author":"L Rejnmark","year":"2006","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2006) Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertens 24:581\u2013589","journal-title":"J Hypertens"},{"key":"1320_CR29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/01.HYP.26.1.60","volume":"26","author":"VL Burt","year":"1995","unstructured":"Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, Brown C, Roccella EJ (1995) Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 26:60\u201369","journal-title":"Hypertension"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-010-1320-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-010-1320-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-010-1320-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:01:12Z","timestamp":1558623672000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-010-1320-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,15]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["1320"],"URL":"https:\/\/doi.org\/10.1007\/s00198-010-1320-4","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,15]]}}}